KVCC wins $300,000 federal grant
Document Actions
CTA Adds GVSU to Statewide Network
For Immediate Release
Core Technology Alliance Adds
Grand Valley State University to Statewide Network
Grand Rapids, Michigan (March 5, 2007) – The Core Technology Alliance (CTA), a collaborative statewide network of advanced research and technology facilities, today announced the addition of Grand Valley State University (GVSU) to its consortium. In 2006, Grand Valley partnered with the Van Andel Institute to establish the Michigan Good Manufacturing Practices facility (MGMP), which will operate under the business name Grand River Aseptic Pharmaceutical Packaging. The MGMP will serve as the alliance’s tenth core.
Currently under construction, the MGMP will help meet a nationwide need for sterile filling and packaging of drugs used in small scale clinical trials. The CTA will market and promote the new facility’s operations as aseptic fill/finish services for small pharmaceutical firms, educational institutions and government entities.
Slated for completion this summer on Grand Valley’s Pew Grand Rapids Campus, the 7,000-square foot clean room facility is designed to package new drugs in sufficient quantity and at a reasonable cost under strict guidelines for purity and sterility for use in early phase human clinical trials.
“It is a pleasure to welcome Grand Valley State University to the CTA as our newest member. The addition of the MGMP as a core facility allows us to provide clients with world-class value in material development services,” said CTA President and CEO George Vande Woude, Ph.D. Vande Woude is also director of research at the Van Andel Institute. “This new GMP core represents yet another unique feature in the drug development pipeline the CTA has built throughout the State of Michigan.”
Formed in 2000 and incorporated in 2004, the CTA makes sophisticated core technologies available on a fee-for-service basis to biotech and pharmaceutical firms, entrepreneurs and researchers. By creating greater access to these technologies, the CTA serves as a catalyst for biotech R&D and development of the life science industry throughout the state.
"Grand Valley is excited to be a member of the Core Technology Alliance,” said Thomas J. Haas, president of Grand Valley. “Our membership represents our strong commitment to economic development in West Michigan and in the rest of the state."
In addition to Grand Valley, CTA members include Kalamazoo Valley Community College, Michigan State University, the University of Michigan, the Van Andel Research Institute, Wayne State University and Western Michigan University. The alliance’s existing core facilities are dedicated to genomics, proteomics, structural biology, animal models, bioinformatics, high throughput screening, antibody technology, pathology services and clinical stage pharmaceutical contract manufacturing services.
Core Technology Alliance Adds
Grand Valley State University to Statewide Network
Grand Rapids, Michigan (March 5, 2007) – The Core Technology Alliance (CTA), a collaborative statewide network of advanced research and technology facilities, today announced the addition of Grand Valley State University (GVSU) to its consortium. In 2006, Grand Valley partnered with the Van Andel Institute to establish the Michigan Good Manufacturing Practices facility (MGMP), which will operate under the business name Grand River Aseptic Pharmaceutical Packaging. The MGMP will serve as the alliance’s tenth core.
Currently under construction, the MGMP will help meet a nationwide need for sterile filling and packaging of drugs used in small scale clinical trials. The CTA will market and promote the new facility’s operations as aseptic fill/finish services for small pharmaceutical firms, educational institutions and government entities.
Slated for completion this summer on Grand Valley’s Pew Grand Rapids Campus, the 7,000-square foot clean room facility is designed to package new drugs in sufficient quantity and at a reasonable cost under strict guidelines for purity and sterility for use in early phase human clinical trials.
“It is a pleasure to welcome Grand Valley State University to the CTA as our newest member. The addition of the MGMP as a core facility allows us to provide clients with world-class value in material development services,” said CTA President and CEO George Vande Woude, Ph.D. Vande Woude is also director of research at the Van Andel Institute. “This new GMP core represents yet another unique feature in the drug development pipeline the CTA has built throughout the State of Michigan.”
Formed in 2000 and incorporated in 2004, the CTA makes sophisticated core technologies available on a fee-for-service basis to biotech and pharmaceutical firms, entrepreneurs and researchers. By creating greater access to these technologies, the CTA serves as a catalyst for biotech R&D and development of the life science industry throughout the state.
"Grand Valley is excited to be a member of the Core Technology Alliance,” said Thomas J. Haas, president of Grand Valley. “Our membership represents our strong commitment to economic development in West Michigan and in the rest of the state."
In addition to Grand Valley, CTA members include Kalamazoo Valley Community College, Michigan State University, the University of Michigan, the Van Andel Research Institute, Wayne State University and Western Michigan University. The alliance’s existing core facilities are dedicated to genomics, proteomics, structural biology, animal models, bioinformatics, high throughput screening, antibody technology, pathology services and clinical stage pharmaceutical contract manufacturing services.